Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by FlintNewellon Oct 31, 2015 11:39pm
195 Views
Post# 24247731

RE:RE:RE:RE:RE:Pharmacist accuses drugmaker of 'massive fraud'

RE:RE:RE:RE:RE:Pharmacist accuses drugmaker of 'massive fraud'
No rational investment decision has ever been made by spreading fear and uncertainty.
 
If you're holding CXR in a diversified portfolio, have a reasonable weighting for it, and are thinking long-term, the magnitude of Valeant's problems is not relevant as a CXR investor. 
 
Let's assume the worst case scenario for Valeant. Assume for the moment that Valeant's issues are worse than they appear. Assume that it is the next Enron and that it will go bankrupt. When Enron went bankrupt, did all energy companies go bankrupt? No. There may have been short-term panic and volatility for companies in the same sector (as there is in the case of CXR) but is Enron's downfall affecting the perception of energy companies today? I would hope not or else you are letting fear and emotions drive your investment strategy.
 
By the same token, if Valeant goes bankrupt, will all healthcare companies go bankrupt? No. There will likely be greater short-term volatility and CXR's share price might significantly drop in the short-term. If the fundamentals of CXR are not affected by these events, then CXR remains a great buy. There is nothing to suggest at the moment that Valeant's immediate problems also apply to CXR.
 
Life will go on, and when we look back at these events years down the road, it will make for some great reading but that’s about it.

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse